Gentherm Reports 2015 First Quarter Results
For the 2015 first quarter, revenues increased 7 percent year over year to
"Once again all of our divisions met or exceeded their operational goals during this year's first quarter, and we are very happy with the strength of our business activity on a global level," said President and CEO
"The strong U.S. Dollar versus the local currencies of the countries where we operate has provided a revenue headwind. Had the 2015 exchange rates been the same as the 2014 rates, our product revenues would have been significantly higher and our growth rate would have been nearly 12 percent over the prior year, which more closely reflects our shipping activity. Even as our consolidated, Dollar-denominated revenues were impacted, we are very pleased with our bottom-line performance and the year-over-year growth in net income."
Coker added that for the fifth quarter in a row gross margins have also been very strong.
"Our gross margin came in around 32 percent, which we are very happy to report. However many factors such as product mix, currency exchange rates and production capacity growth can impact our gross margins on a quarter-to-quarter basis. With that said, we still believe the best gross margin target for
First Quarter Financial Highlights
For the 2015 first quarter, revenues were up 7 percent to
Foreign currency translation of the Company's Euro-denominated product revenue for this year's first quarter had an impact on its product revenue results since the average U.S. Dollar/Euro exchange rate in this year's first quarter was 1.13 compared to 1.37 in the first quarter of 2014.
CCS revenue in the 2015 first quarter, compared to the 2014 first quarter, increased by
Seat heater revenue in this year's first quarter decreased year-over-year by approximately
Net income for the 2015 first quarter was
Gross margin as a percentage of revenue for this year's first quarter increased to 32.2 percent, up from 29.4 percent for the 2014 first quarter. The increase was due to a favorable change in product mix, greater coverage of fixed costs at the higher volume levels, and a benefit from foreign currency impact on production expenses in foreign currencies. The favorable product mix was primarily attributable to the greater sales growth in CCS products on which we have historically had better margin performance. The stronger U.S. Dollar during the quarter resulted in lower production costs totaling
Adjusted EBITDA for the 2015 first quarter was
Research and Development, Selling, General and Administrative (SG&A) Expenses
Net research and development expenses for the 2015 first quarter were up year over year
Selling, general and administrative expenses for the 2015 first quarter were
Guidance
Barring unforeseen economic turbulence, including in the European market or further strengthening of the U.S. Dollar, the 2015 revenue growth outlook remains strong. The Company is expecting revenue for 2015 to increase 10 to 15 percent over 2014 revenue, which was
Conference Call
As previously announced,
About
Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding future sales, products, opportunities, markets, expenses and profits. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. Those risks include, but are not limited to, risks that sales may not increase, additional financing requirements may not be available, new competitors may arise and adverse conditions in the industry in which the Company operates may negatively affect its results. Those and other risks are described in the Company's annual report on Form 10-K for the year ended
|
Contact: |
Allen & Caron Inc |
|
Mike Mason (investors) |
|
|
(212) 691-8087 |
|
|
Rene Caron (investors) |
|
|
Len Hall (media) |
|
|
(949) 474-4300 |
TABLES FOLLOW
|
GENTHERM INCORPORATED CONSOLIDATED CONDENSED STATEMENTS OF INCOME (In thousands, except per share data) (Unaudited) |
|||||||
|
Three Months Ended |
|||||||
|
2015 |
2014 |
||||||
|
Product revenues |
$ |
206,909 |
$ |
193,938 |
|||
|
Cost of sales |
140,339 |
136,913 |
|||||
|
Gross margin |
66,570 |
57,025 |
|||||
|
Operating expenses: |
|||||||
|
Net research and development expenses |
14,548 |
13,045 |
|||||
|
Acquisition transaction expenses |
— |
1,075 |
|||||
|
Selling, general and administrative |
24,945 |
17,867 |
|||||
|
Total operating expenses |
39,493 |
31,987 |
|||||
|
Operating income |
27,077 |
25,038 |
|||||
|
Interest expense |
(564) |
(931) |
|||||
|
Revaluation of derivatives loss |
(964) |
(247) |
|||||
|
Foreign currency gain (loss) |
435 |
(1,523) |
|||||
|
Gain from equity investment |
— |
785 |
|||||
|
Other income (expense) |
195 |
(241) |
|||||
|
Earnings before income tax |
26,179 |
22,881 |
|||||
|
Income tax expense |
6,359 |
6,302 |
|||||
|
Net income |
$ |
19,820 |
$ |
16,579 |
|||
|
Basic earnings per share |
$ |
0.55 |
$ |
0.47 |
|||
|
Diluted earnings per share |
$ |
0.55 |
$ |
0.47 |
|||
|
Weighted average number of shares – basic |
35,769 |
35,064 |
|||||
|
Weighted average number of shares – diluted |
36,245 |
35,592 |
|||||
|
GENTHERM INCORPORATED RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME (Unaudited, in thousands) |
||
|
Three Months Ended March 31, |
||
|
2015 |
2014 |
|
|
Net income |
$ 19,820 |
$ 16,579 |
|
Add Back: |
||
|
Income tax expense |
6,359 |
6,302 |
|
Interest expense |
564 |
931 |
|
Depreciation and amortization |
7,436 |
7,318 |
|
Adjustments: |
||
|
Acquisition transaction expense |
– |
1,075 |
|
Unrealized currency loss |
873 |
1,266 |
|
Unrealized revaluation of derivatives |
(940) |
(1,025) |
|
Adjusted EBITDA |
$ 34,112 |
$ 32,446 |
Use of Non-GAAP Financial Measures
In evaluating its business,
The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income or other consolidated income statement data prepared in accordance with GAAP.
GENTHERM INCORPORATED |
||||||||||
|
ACQUISITION TRANSACTION EXPENSES, PURCHASE ACCOUNTING IMPACTS AND OTHER EFFECTS |
||||||||||
|
(Unaudited and in thousands, except per share data) |
||||||||||
|
Three Months Ended March 31, |
Future Full Year Periods (estimated) |
|||||||||
|
2015 |
2014 |
2015 |
2016 |
2017 |
Thereafter |
|||||
|
Transaction related current expenses |
||||||||||
|
Acquisition transaction expenses |
$ – |
$ 1,075 |
$ – |
$ – |
$ – |
$ – |
||||
|
Non-cash purchase accounting impacts |
||||||||||
|
Customer relationships amortization |
$ 1,792 |
$ 2,056 |
$ 6,845 |
$ 6,845 |
$ 6,845 |
$ 23,659 |
||||
|
Technology amortization |
771 |
862 |
2,947 |
2,947 |
2,115 |
2,043 |
||||
|
Product development costs amortization |
265 |
569 |
1,011 |
41 |
– |
– |
||||
|
Trade name amortization |
46 |
– |
180 |
180 |
135 |
– |
||||
|
$ 2,874 |
$ 3,487 |
$ 10,983 |
$ 10,013 |
$ 9,095 |
$ 25,702 |
|||||
|
Tax effect |
(669) |
(1,195) |
(2,559) |
(2,334) |
(2,121) |
(6,042) |
||||
|
Net income effect |
$ 2,205 |
$ 3,367 |
$ 8,424 |
$ 7,679 |
$ 6,974 |
$ 19,660 |
||||
|
Earnings per share - difference |
||||||||||
|
Basic |
$ 0.06 |
$ 0.10 |
||||||||
|
Diluted |
$ 0.06 |
$ 0.09 |
||||||||
|
GENTHERM INCORPORATED CONSOLIDATED BALANCE SHEETS (In thousands, except share data) (Unaudited) |
|||||||
|
March 31, |
December 31, |
||||||
|
ASSETS |
|||||||
|
Current Assets: |
|||||||
|
Cash and cash equivalents |
$ |
79,581 |
$ |
85,700 |
|||
|
Accounts receivable, less allowance of $2,858 and $2,847, respectively |
147,545 |
136,183 |
|||||
|
Inventory: |
|||||||
|
Raw materials |
51,404 |
48,678 |
|||||
|
Work in process |
4,508 |
4,009 |
|||||
|
Finished goods |
24,233 |
24,956 |
|||||
|
Inventory, net |
80,145 |
77,643 |
|||||
|
Derivative financial instruments |
2,362 |
145 |
|||||
|
Deferred income tax assets |
5,532 |
6,247 |
|||||
|
Prepaid expenses and other assets |
31,510 |
29,107 |
|||||
|
Total current assets |
346,675 |
335,025 |
|||||
|
Property and equipment, net |
92,444 |
91,727 |
|||||
|
Goodwill |
27,673 |
30,398 |
|||||
|
Other intangible assets |
58,171 |
68,129 |
|||||
|
Deferred financing costs |
377 |
406 |
|||||
|
Deferred income tax assets |
22,007 |
18,843 |
|||||
|
Derivative financial instruments |
4,821 |
1,345 |
|||||
|
Other non-current assets |
11,126 |
12,019 |
|||||
|
Total assets |
$ |
563,294 |
$ |
557,892 |
|||
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||
|
Current Liabilities: |
|||||||
|
Accounts payable |
$ |
84,544 |
$ |
71,434 |
|||
|
Accrued liabilities |
55,496 |
68,387 |
|||||
|
Current maturities of long-term debt |
4,657 |
5,306 |
|||||
|
Derivative financial instruments |
4,817 |
2,466 |
|||||
|
Total current liabilities |
149,514 |
147,593 |
|||||
|
Pension benefit obligation |
9,515 |
10,321 |
|||||
|
Other liabilities |
5,460 |
2,788 |
|||||
|
Long-term debt, less current maturities |
81,126 |
85,469 |
|||||
|
Derivative financial instruments |
9,017 |
6,698 |
|||||
|
Deferred income tax liabilities |
11,026 |
10,804 |
|||||
|
Total liabilities |
265,658 |
263,673 |
|||||
|
Shareholders' equity: |
|||||||
|
Common Stock: |
|||||||
|
No par value; 55,000,000 shares authorized, 35,890,326 and 35,696,334 issued and outstanding at March 31, 2015 and December 31, 2014, respectively |
246,133 |
243,255 |
|||||
|
Paid-in capital |
(8,185) |
(8,224) |
|||||
|
Accumulated other comprehensive loss |
(45,063) |
(25,743) |
|||||
|
Accumulated earnings |
104,751 |
84,931 |
|||||
|
Total shareholders' equity |
297,636 |
294,219 |
|||||
|
Total liabilities and shareholders' equity |
$ |
563,294 |
$ |
557,892 |
|||
|
GENTHERM INCORPORATED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) |
|||||||||
|
Three Months Ended March 31, |
|||||||||
|
2015 |
2014 |
||||||||
|
Operating Activities: |
|||||||||
|
Net income |
$ |
19,820 |
$ |
16,579 |
|||||
|
Adjustments to reconcile net income to cash provided by (used in) operating activities: |
|||||||||
|
Depreciation and amortization |
7,459 |
7,473 |
|||||||
|
Deferred income tax benefit |
(2,483) |
(1,804) |
|||||||
|
Stock compensation |
1,358 |
870 |
|||||||
|
Defined benefit plan (income) expense |
(9) |
1 |
|||||||
|
Provision of doubtful accounts |
125 |
(4) |
|||||||
|
Gain on revaluation of financial derivatives |
(324) |
(557) |
|||||||
|
Gain from equity investment |
— |
(785) |
|||||||
|
Excess tax benefit from equity awards |
— |
(2,173) |
|||||||
|
(Gain) loss on sale of property and equipment |
(8) |
24 |
|||||||
|
Changes in operating assets and liabilities: |
|||||||||
|
Accounts receivable |
(15,994) |
(21,153) |
|||||||
|
Inventory |
(5,762) |
457 |
|||||||
|
Prepaid expenses and other assets |
(3,905) |
(5,786) |
|||||||
|
Accounts payable |
15,522 |
2,798 |
|||||||
|
Accrued liabilities |
(6,970) |
904 |
|||||||
|
Net cash provided by (used in) operating activities |
8,829 |
(3,156) |
|||||||
|
Investing Activities: |
|||||||||
|
Investment in subsidiary, net of cash acquired |
(47) |
(628) |
|||||||
|
Proceeds from the sale of property and equipment |
181 |
44 |
|||||||
|
Purchases of property and equipment |
(10,403) |
(6,769) |
|||||||
|
Net cash used in investing activities |
(10,269) |
(7,353) |
|||||||
|
Financing Activities: |
|||||||||
|
Borrowing of debt |
— |
13,455 |
|||||||
|
Repayments of debt |
(1,669) |
(6,965) |
|||||||
|
Excess tax benefit from equity awards |
— |
2,173 |
|||||||
|
Cash paid for the cancellation of restricted stock |
(467) |
— |
|||||||
|
Proceeds from the exercise of Common Stock options |
2,026 |
1,634 |
|||||||
|
Net cash provided by (used in) financing activities |
(110) |
10,297 |
|||||||
|
Foreign currency effect |
(4,569) |
2,978 |
|||||||
|
Net increase (decrease) in cash and cash equivalents |
(6,119) |
2,766 |
|||||||
|
Cash and cash equivalents at beginning of period |
85,700 |
54,885 |
|||||||
|
Cash and cash equivalents at end of period |
$ |
79,581 |
$ |
57,651 |
|||||
|
Supplemental disclosure of cash flow information: |
|||||||||
|
Cash paid for taxes |
$ |
14,768 |
$ |
4,689 |
|||||
|
Cash paid for interest |
$ |
515 |
$ |
725 |
|||||
|
Supplemental disclosure of non-cash transactions: |
|||||||||
|
Common Stock issued to Board of Directors and employees |
$ |
673 |
$ |
495 |
|||||
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gentherm-reports-2015-first-quarter-results-300074880.html
SOURCE